Download Free FREE High-quality Joomla! Designs • Premium Joomla 3 Templates

World News

India innovated new rotavirus vaccine ROTAVAC


A new, cheaper, and heat-stable rotavirus vaccine could prevent thousands of childhood deaths. Vaccine maker Bharat Biotech announced that the World Health Organisation (WHO) has granted prequalification to its rotavirus vaccine ROTAVAC, used for prevention of infant deaths and hospitalizations due to rotavirus diarrhea. WHO prequalification is necessary for the …

Read More »

GSK CEO: Looking at Pfizer consumer business

GlaxoSmithKline’s new chief executive said on Tuesday that the British drugmaker would have a look at Pfizer Inc’s consumer products business, but would not overpay for the asset. Pfizer, the largest U.S. drugmaker, said last year it was considering strategic alternatives, including a sale or spinoff, of the consumer business, …

Read More »

FDA panel backs Novartis’ pioneering new cancer gene therapy


Novartis AG’s pioneering new cancer drug won enthusiastic support from a federal advisory panel on Wednesday, paving the way for approval of the first US gene therapy. The panel unanimously recommended that the Food and Drug Administration approve the drug, tisagenlecleucel, for patients ages 3 to 25 with relapsed B-cell …

Read More »

FDA approves 1st cholera vaccine Vaxchora in US


The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera. Cholera, a disease caused by Vibrio cholerae …

Read More »

Pakistan bans contraceptives advertisements


The Pakistan Electronic Media Regulatory Authority (Pemra) has issued a notice to all TV channels and radio stations across the country to “immediately stop” airing advertisements related to contraceptives and family planning products. The decision comes in the wake of numerous complaints received by the regulatory authority against “undesired” content …

Read More »

Haia objects to feminization of pharmacies


The Commission for the Promotion of Virtue and Prevention of Vice (Haia) is opposing the feminization of pharmacies, the Jeddah Chamber of Commerce and Industry (JCCI) confirmed. Haia has objected even if there are barriers between men and women in the shop, and despite pharmacies in malls employing women, Ibrahim …

Read More »

FDA grants Breakthrough Therapy for ocrelizumab in multiple sclerosis


Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM) for the treatment of people with primary progressive multiple sclerosis (PPMS). There are currently no approved treatments for PPMS, a debilitating form of MS characterised by steadily worsening …

Read More »

$1 billion dollar drug bust in Australia


(Rajon Pandit): Australian police discovered millions of dollars worth of drugs hidden inside a shipment of bras, part of what they said Monday was the country’s biggest ever liquid methamphetamine bust. Officers found more than Aus$1 billion (US$712 million) of the lethally-addictive drug — also known as ice — in …

Read More »

Bharat Biotech develops world’s first Zika vaccine


Hyderabad-based Bharat Biotech has filed for global patent of two vaccine candidates – a recombinant vaccine and an inactivated vaccine – for Zika virus. The company announced that it could make available the inactivated vaccine in two years if the Indian Government fast-tracked the regulatory approvals once the pre-clinical trials proved to be successful. Addressing a press conference here on …

Read More »

Sanofi provides key support to the Human Vaccines Project

Sanofi Pasteur, the vaccines division of Sanofi, has signed an agreement with the Human Vaccines Project Inc. to partially fund the non-profit, public-private partnership convening leading academic researchers and industrial partners to solve the primary problems impeding vaccine/immunotherapy development by “decoding” the human immune system. The Project is a global …

Read More »

Novartis continues to grow immuno-oncology pipeline through collaboration and licensing agreement with Surface Oncology


Novartis has announced that it is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell populations, inhibitory cytokines, and immunosuppressive metabolites in the tumor microenvironment. These programs …

Read More »